Navigation Links
Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis
Date:2/20/2009

cancer testing, and this study demonstrates the commitment of our science and innovation team to advancing cancer research," said Surya N. Mohapatra, Ph.D., Chairman and Chief Executive Officer, Quest Diagnostics.

CLL is a blood cancer that usually progresses slowly over many years. In this disease, abnormal white blood cells called B-cells accumulate in the blood and the bone marrow. The lymph nodes, spleen, and other organs may also be affected. Although CLL is the most common form of leukemia in adults in Western countries, little is known about what causes the disease or how it develops.

Previous research by the NCI/FDA team and others showed that some family members of CLL patients can have B-cells in their blood that have outer-surface proteins that are similar to proteins found on CLL cells. This abnormal condition, known as monoclonal B-cell lymphocytosis (MBL), occurs in over 10 percent of CLL family members and in about 3 percent to 5 percent of healthy adults over the age of 50, suggesting it might be a precursor of CLL.

In the current study, the research team identified 45 individuals among the more than 77,000 participants in the nationwide Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial who were cancer-free upon entering the trial, were later diagnosed with CLL, and had frozen blood samples available for analysis that had been collected upon their enrollment in PLCO. Using sophisticated laboratory techniques developed by Quest Diagnostics to analyze the blood samples, the researchers found that 44 of the 45 CLL patients had MBL between six months to more than six years prior to their CLL diagnosis. Prior research shows that the MBL cells were identified by examining cell-surface proteins, or CLL markers, using a method called flow cytometry, and by using molecular techniques to confirm the presence of certain rearranged genes, known as immunoglobulin heavy variable (IGHV) group ge
'/>"/>

SOURCE Quest Diagnostics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
4. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
5. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
6. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
7. BioMosaics Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe
8. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in Miami
9. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
10. Microlifes Home Blood Pressure Monitors Proven Accurate Even for Critical Patients
11. WaveSense Blood Glucose Meter One of Few Brands to Pass Rigorous TNO Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... MANCHESTER, N.H. , March 2, 2015 ... leading provider of professional-grade vitamins, supplements, prescription ... today announced a strategic partnership with Anabolic ... products for healthcare professionals. This new partnership ... reach into new licensed healthcare practitioner segments ...
(Date:3/2/2015)... Inc. (NYSE MKT: IG), a New Jersey based specialty generic ... and year ended December 31, 2014. Fourth Quarter ... revenues of $13.7 million in the fourth quarter of 2014, ... , Total revenues of $33.7 million for the year ... same period in 2013 , Total net revenues generated ...
(Date:3/2/2015)... Therapeutics, Inc. (NASDAQ: HALO ) today reported financial results ... 2014. Financial highlights for the fourth quarter include revenues of ... $0.04 per share. This compares to revenues of $12.5 million ... share, for the fourth quarter of 2013. Financial highlights for ... a net loss of $68.4 million, or $0.56 per share. ...
Breaking Medicine Technology:Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 2Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 3IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 2IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 3IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 4IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 5IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 6IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 7IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 8IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 9IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 10IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 11IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 12Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 2Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 3Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 4Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 5Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 6Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 7Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 8Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 9
... Conference on Avian,Influenza at France's Pasteur Institute, PARIS, ... of,Novavax Inc.'s pandemic influenza vaccine provided protection,against a ... data presented here today at the Second International,Conference ... show that two 0.6 microgram doses of Novavax's,virus-like ...
... of Rare but Devastating,Condition , LONDON, June 1, ... of Leicester and have today (Friday June 1),announced ... rare but,devastating medical condition that can affect children ... clinicians and scientists from the two,universities have already ...
Cached Medicine Technology:Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 2Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 3Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 2World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 3World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 5
(Date:3/2/2015)... PA (PRWEB) March 02, 2015 Surgeons ... of the Allegheny Health Network, are exploring ... new software called Visual Info Zonal Reminder (VIZR), to ... Introduced in 2013, Google Glass is a wearable technology ... a smartphone-like hands-free format. Wearers communicate with the Internet ...
(Date:3/2/2015)... UK (PRWEB) March 02, 2015 Market ... research reports worked out by Global Industry Analysts Inc ... Therapy Equipment: Market Research Report . Through 2018, the ... a 6.04% CAGR. The detailed research report suggests a ... for radiation therapy equipment as well as covers the ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 While many ... Title VI of the Civil Rights Act, the unique ... hearing loss are bringing light to the value of ... reveal that nearly 1 in 20 U.S. children have ... 10 in some major cities.(1) Stratus Video Interpreting ...
(Date:3/2/2015)... 02, 2015 Gummy smile reduction ... Gum reshaping can involve one or several procedures to reduce ... gum tissue for a more even gum line. Dr. Farnoosh ... treatment that can permanently lighten discolored or naturally dark ... which involves a personalized treatment plan to address a patient’s ...
(Date:3/2/2015)... York, New York (PRWEB) March 02, 2015 ... Creative Recovery at Recovery Unplugged™—will be delivering a ... A Singer/Songwriter's Perspective on the Art of Healing ... Addiction Disorders (NCAD) and Behavioral Healthcare Executive Summit ... his name, Mr. Supa’s songs have been recorded ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 3Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2
... MA Brandeis University selected Jay and Maureen Neitz, the husband-and-wife ... gene therapy to treat vision disorders, as the inaugural recipients ... The award is funded by a $1 million endowment established ... ,75 and Susan K. Feigenbaum ,74, his wife. The endowment ...
... ... is a uniquely designed, extremely resilient, ‘two-in-one’ foam roller. This patented foam roller has ... of the most versatile foam rollers available. , ... Minneapolis, MN (PRWEB) December 17, 2009 -- The SMARTROLLER® ...
... accompanying lung infections , THURSDAY, Dec. 17 (HealthDay News) -- ... flu virus, and researchers say they,ve found a clue as ... illness appears to be a molecule called interleukin 17 (TH17), ... Researchers who analyzed levels of the molecule in swine-flu patients ...
... ... is pleased to announce its newly redesigned Web site: www.psanj.com . PSANJ is a ... as New York magazine and New Jersey Monthly. , ... New Brunswick, NJ (PRWEB) December 17, 2009 -- Plastic Surgery Arts ...
... ... Important ,for the R&D Informatics Industry, , ... Needham, MA (PRWEB) December 17, 2009 -- Cambridge Healthtech Institute ... 2nd Annual Adopting R&D Informatics Systems conference to be held on February 3-5, 2010 ...
... ... Byrne to lead the firm’s Interim Leadership division as senior vice president. A seasoned executive ... B. E. Smith today. , ... Lenexa, KS (Vocus) December 17, 2009 -- B. E. Smith recently hired Deirdre ...
Cached Medicine News:Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2Health News:OPTP Introduces the SMARTROLLER 2Health News:Plastic Surgery Arts of New Jersey (PSANJ) Launches New Web Site 2Health News:Plastic Surgery Arts of New Jersey (PSANJ) Launches New Web Site 3Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 3Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 2Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 3
... Digital Multichannel, with it's streamlined ... of routine laboratory tasks. The ... features: Soft-touch tip ejection, Super ... (0.5-10ul models), Entire pipette autoclavable, ...
... wide variety of applications. • Whole pipette is ... freely rotated against the handle to work in ... angle towards the microtiter plate. • The special ... common pipette tips, and provides a firm, parallel ...
... to operate in a wide variety of applications. ... The manifold can be freely rotated against the ... always at an optimum angle towards the microtiter ... the use of most common pipette tips, and ...
... Features and Benefits: 1-8channel ... a new product number, created ... number. If showing no availability ... old Sigma-Aldrich number (Z37,174-2) or ...
Medicine Products: